Detalles de la búsqueda
1.
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
BMC Cancer
; 18(1): 654, 2018 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29902993
2.
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Breast Cancer Res
; 14(2): R47, 2012 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22420423
3.
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Breast Cancer Res
; 14(4): R117, 2012 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22889108
4.
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.
BMC Cancer
; 12: 616, 2012 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23259667
5.
Medical students' cognitive and affective attitudes towards learning and using communication skills--a nationwide cross-sectional study.
Med Teach
; 30(3): 272-9, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18484454
6.
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer.
Clin Cancer Res
; 12(20 Pt 1): 6000-4, 2006 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17062672
7.
Assessing medical students' attitudes towards learning communication skills--which components of attitudes do we measure?
BMC Med Educ
; 7: 4, 2007 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17394673
8.
Curriculum factors influencing knowledge of communication skills among medical students.
BMC Med Educ
; 7: 35, 2007 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17925041
9.
Comparing self-reported communication skills of medical students in traditional and integrated curricula: a nationwide study.
Patient Educ Couns
; 58(3): 271-8, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16061342
10.
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Mol Oncol
; 9(8): 1553-64, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26004085
11.
Use of Alternative Medicine Among Norwegian Cancer Patients is Associated with Mental Distress - A Follow-up Study.
Acta Oncol
; 41(7-8): 646-651, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-28758867
12.
[Should complementary therapies be offered in hospitals?]. / Tilbud om komplementaer behandling i sykehus?
Tidsskr Nor Laegeforen
; 124(23): 3078-80, 2004 Dec 02.
Artículo
en Nor
| MEDLINE | ID: mdl-15586193
13.
[Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]. / Skal alternative utøvere behandle kreft--hva mener onkologiske helsearbeidere?
Tidsskr Nor Laegeforen
; 123(21): 3059-61, 2003 Nov 06.
Artículo
en Nor
| MEDLINE | ID: mdl-14618177
14.
[Teaching clinical communication to medical students in Norway]. / Undervisning i klinisk kommunikasjon for medisinstudenter i Norge.
Tidsskr Nor Laegeforen
; 123(16): 2277-80, 2003 Aug 28.
Artículo
en Nor
| MEDLINE | ID: mdl-14508554
15.
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
J Clin Oncol
; 32(34): 3848-57, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25366688
16.
Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.
PLoS One
; 6(4): e19249, 2011 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21556366
17.
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
PLoS One
; 3(8): e3062, 2008 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-18725978
18.
Use of alternative medicine among Norwegian cancer patients is associated with mental distress--a follow-up study.
Acta Oncol
; 41(7-8): 646-51, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-14651209
19.
Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer.
Acta Oncol
; 43(1): 11-4, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15068314
20.
Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer.
Acta Oncol
; 43(2): 186-9, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15163168